Re: Material information withheld?
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 12:07PM
|
Re: DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
3
|
Resverlogix Corp.
|
Apr 09, 2020 02:38AM
|
Re: Bromodomain-2 Selective BET inhibitors
|
2
|
Resverlogix Corp.
|
Apr 21, 2018 11:57PM
|
Re: archived presentation is up. still no audio
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 10:04AM
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
2
|
Resverlogix Corp.
|
Feb 12, 2021 05:01PM
|
Re: Repetitive musings on repetitive issues
|
2
|
Resverlogix Corp.
|
Feb 12, 2021 05:07PM
|
BET bromodomain protein inhibitors and AML
|
2
|
Zenith Epigenetics
|
Aug 29, 2017 07:07PM
|
Re: COVID-19 "competition" to keep an eye on.
|
2
|
Resverlogix Corp.
|
Feb 12, 2021 05:36PM
|
Re: Renal trial delayed (again)
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 06:06PM
|
Re: Reiterating from ClinicalTrials.gov
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 01:36PM
|
Another, but already on company site
|
2
|
Resverlogix Corp.
|
Apr 14, 2023 01:39PM
|
European Medical Journal - Sorry if posted already, didn't see
|
2
|
Resverlogix Corp.
|
Nov 06, 2015 07:09PM
|
Re: Leave early!
|
2
|
Resverlogix Corp.
|
Sep 30, 2019 12:28AM
|
Epilepsy? Two links with partial quote from the first
|
2
|
Resverlogix Corp.
|
Aug 22, 2020 06:39AM
|
Re: A Better Forum Compared With Stockhouse?
|
2
|
Resverlogix Corp.
|
May 06, 2015 07:59AM
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
2
|
Resverlogix Corp.
|
Aug 13, 2019 05:37PM
|
Re: BET inhibitor and BRD4 papers keep piling up
|
2
|
Resverlogix Corp.
|
Sep 25, 2017 09:24PM
|
Also interesting, but less encouraging
|
2
|
Resverlogix Corp.
|
Aug 01, 2022 04:56AM
|
Re: Also interesting, but less encouraging
|
2
|
Resverlogix Corp.
|
Aug 03, 2022 01:56PM
|
Re: Great Discussion
|
2
|
Resverlogix Corp.
|
Oct 18, 2017 06:19PM
|